Gefarma

What Gefarma does

Gefarma is an authorized medical and pharmaceutical distributor operating in Equatorial Guinea since 2010, specializing in four core product categories: infant nutrition, medications, laboratory materials, and hospital equipment. The company sources from more than 200 international suppliers — including Roche, Bayer, Novartis, Johnson & Johnson, Merck, Abbott, Grifols, Fresenius, Philips, 3M, and B. Braun — through its Central de Compras (purchasing hub) in Valencia, Spain, which provides port-adjacent logistics for importation into Equatorial Guinea. All products are stated to comply with EU C.E.E. legislation under the accreditation of parent corporation Safadi Group.

The company's revenue model is B2B distribution: it sells one-time purchases of pharmaceutical and medical products on a quote-based basis to over 400 pharmacies and to major hospitals including La Paz de Bata and Centro Médico La Paz de Malabo, eliminating intermediaries through direct in-country presence. Gefarma also participates in the Government of Equatorial Guinea's HORIZONTE 2020 modernization program, supplying medications for malaria, HIV, and national vaccination initiatives, and operates the DOM — the country's first commercial center dedicated to Health and Beauty — in Malabo. A Medical Research Center of Guinea is listed as a planned future facility.

Gefarma is a subsidiary of Safadi Group, a diversified conglomerate with units in textile, food, iron, and real estate sectors. It maintains operational offices in both major cities of Equatorial Guinea (Malabo and Bata) and reports 12 employees. The business model is sales-led direct distribution, relying on personal B2B relationships, a bilingual Spanish/English corporate website, and direct contact rather than digital channels for customer acquisition.

Name

Gefarma

Legal name

Gefarma

Website

https://gefarma.net

Company type

Private

Founded year

2010

Operating status

Operating

Short description

Gefarma is an authorized pharmaceutical and medical-products distributor in Equatorial Guinea, sourcing from 200+ international suppliers via a Valencia purchasing hub and selling directly to 400+ pharmacies and major government hospitals across Malabo and Bata.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industry

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

• Pharmaceutical distribution
• Medical supplies
• Hospital equipment
• Infant nutrition
• Laboratory materials

Headquarters

HQ city

Malabo

HQ country

Equatorial Guinea

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Medical and pharmaceutical product distribution: Distribution of infant nutrition, medications, laboratory materials, and hospital equipment to pharmacies and hospitals throughout Guinea Equatorial. Acts as authorized distributor purchasing from international suppliers and reselling to healthcare facilities.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

Gefarma is an authorized distributor operating in Equatorial Guinea since 2010. It procures, imports, and distributes four core product categories: infant nutrition, medications, laboratory materials, and hospital equipment. The company serves over 400 pharmacies and major hospitals in the country, leveraging a purchasing central in Valencia, Spain that works with 200+ international pharmaceutical and medical suppliers.

Product overview

Gefarma is an authorized distributor operating in Equatorial Guinea since 2010, specializing in four core product categories: infant nutrition (alimentación infantil), medications (medicamentos), laboratory materials (material para laboratorios), and hospital equipment (equipamiento hospitalario). The company distributes to over 400 pharmacies and major hospitals including La Paz de Bata and Centro Médico La Paz de Malabo. Gefarma also operates the DOM commercial center dedicated to Health and Beauty in Malabo, and is developing a future Medical Research Center of Guinea. With purchasing headquarters in Valencia, Spain, and over 200 international suppliers, the company offers comprehensive supply chain services including sourcing, importation, storage, and logistics management across its two main operational locations in Malabo and Bata.

Differentiator

Problem solved

Functional benefit

Products and services

• Medicamentos (Medications) Authorized distribution of medications to more than 400 pharmacies and major hospitals across Equatorial Guinea, including La Paz de Bata and Centro Médico La Paz de Malabo. Sourced from over 200 international pharmaceutical suppliers via the Valencia purchasing hub.
• Alimentación Infantil (Infant Nutrition) Authorized distribution of infant nutrition products to pharmacies in Equatorial Guinea, complying with European C.E.E. legislation via Safadi Group affiliation.
• Material para Laboratorios (Laboratory Materials) Supply of laboratory materials to healthcare facilities in Equatorial Guinea, sourced from more than 200 international pharmaceutical and medical supply providers.
• Equipamiento Hospitalario (Hospital Equipment) Provision of hospital equipment and medical supplies to major hospitals in Equatorial Guinea with full logistics support ensuring proper conservation during transport and storage.

Quantifiable outcome

• Supplies medications to over 400 pharmacies in Guinea
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered flagship and core.

• Safadi GroupflagshipStrategic or Co-development Partner · 1 January 2010Parent corporation with business units in textile, food, ferrous, and real estate sectors. Has accredited healthcare division for drug and medical material distribution. Gefarma operates as part of Safadi Group with EU C.E.E. compliant products.
• Marathon Oil CompanycoreStrategic or Co-development PartnerCollaborative partnership on the 'Ver bien para aprender mejor' (See well to learn better) solidarity project promoting ophthalmological reviews in Guinean schools.
• Government of the Republic of Equatorial GuineaflagshipStrategic or Co-development PartnerIntegration into HORIZONTE 2020 government modernization program for diversification of economic growth sources. Participation in national healthcare programs for malaria, HIV treatment, and vaccination campaigns.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Aspen Pharmacare: Largest pharmaceutical company in Africa (JSE-listed), with deep authorized distribution across sub-Saharan markets. Highly comparable authorized-distributor model with multinational supplier relationships and a focus on essential medicines and hospital products in African markets.
• Adcock Ingram: Major South African pharmaceutical manufacturer and distributor supplying hospitals and pharmacies across the African continent. Comparable business model combining supplier partnerships, hospital-channel distribution, and pharmacy reach in sub-Saharan Africa.
• Missionpharma: Danish pharmaceutical wholesaler specializing in the distribution of medicines and medical supplies to developing countries and humanitarian programs. Closely comparable authorized-distributor model targeting LMICs with broad supplier-side relationships.
• IDA Foundation: Amsterdam-based pharmaceutical wholesaler that supplies essential medicines and medical supplies to low- and middle-income countries. Directly comparable procurement-and-distribution business model for hospitals and public-sector health programs.
• Crown Agents: UK-headquartered international development company that procures and distributes pharmaceuticals and medical supplies for governments and donors in emerging markets. Closely comparable procurement-to-last-mile model for public-sector healthcare customers in Africa and beyond.

Emerging players

• Cipla: Indian multinational pharmaceutical company with a major and growing sub-Saharan Africa footprint, including both manufacturing and authorized distribution through local partners. Relevant as both a supplier of products distributed by Gefarma and a competing distribution presence across Africa.

Broad incumbents

• McKesson: World's largest pharmaceutical distributor and wholesaler (NYSE-listed), serving hospitals, pharmacies, and governments globally. Relevant as the global benchmark for authorized pharmaceutical distribution scale, technology, and supplier breadth.
• Cencora (formerly AmerisourceBergen): Top-tier global pharmaceutical distributor (NYSE-listed) with broad hospital, pharmacy, and manufacturer services. Comparable wholesale-distribution business model and supplier-side relationships, though at vastly greater scale and geographic breadth.
• Cardinal Health: Major US-headquartered pharmaceutical distributor (NYSE-listed) with international wholesale operations. Relevant as a large-scale reference point for the authorized-distribution model Gefarma operates, including hospital-channel supply.
• Walgreens Boots Alliance: Global pharmacy-led enterprise with extensive wholesale-distribution operations through Alliance Healthcare across Europe and emerging markets. Comparable in combining pharmaceutical distribution with retail pharmacy presence (analogous to Gefarma's hospital + 400-pharmacy model).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gefarma